121 related articles for article (PubMed ID: 34963026)
21. Central Venous Catheters and Bloodstream Infection During Induction Therapy in Children With Acute Lymphoblastic Leukemia.
Bergmann K; Hasle H; Asdahl P; Handrup MM; Wehner PS; Rosthøj S; Schrøder H
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e82-7. PubMed ID: 26907653
[TBL] [Abstract][Full Text] [Related]
22. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
[TBL] [Abstract][Full Text] [Related]
23. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
[TBL] [Abstract][Full Text] [Related]
24. Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia.
Chen J; Ngo D; Aldoss I; Shayani S; Tsai NC; Pullarkat V
Leuk Lymphoma; 2019 May; 60(5):1187-1192. PubMed ID: 30322332
[TBL] [Abstract][Full Text] [Related]
25. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
Fotiou D; Sergentanis TN; Papageorgiou L; Stamatelopoulos K; Gavriatopoulou M; Kastritis E; Psaltopoulou T; Salta S; Van Dreden P; Sangare R; Larsen AK; Terpos E; Elalamy I; Dimopoulos MA; Gerotziafas GT
Blood Cancer J; 2018 Nov; 8(11):102. PubMed ID: 30405097
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
Kashanian SM; Holtzman NG; Patzke CL; Cornu J; Duffy A; Koka M; Niyongere S; Duong VH; Baer MR; Apata J; Kamangar F; Emadi A
Cancer Chemother Pharmacol; 2021 Jun; 87(6):817-826. PubMed ID: 33677674
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
28. Venous Thromboembolism After Peripherally Inserted Central Catheters Placement in Children With Acute Leukemia: A Single-center Retrospective Cohort Study.
Ren Y; Chang L; Zhao B; Zhang X; Wan Y; Zhu X; Zhang H
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e407-e409. PubMed ID: 32427704
[TBL] [Abstract][Full Text] [Related]
29. When children become adults and adults become most hypercoagulable after trauma: An assessment of admission hypercoagulability by rapid thrombelastography and venous thromboembolic risk.
Liras IN; Rahbar E; Harting MT; Holcomb JB; Cotton BA
J Trauma Acute Care Surg; 2016 May; 80(5):778-82. PubMed ID: 26886005
[TBL] [Abstract][Full Text] [Related]
30. Promising biomarkers for the prediction of catheter-related venous thromboembolism in hospitalized children: An exploratory study.
Nossair F; Mahajerin A; Hoang J; Diaz D; Nugent D
Pediatr Blood Cancer; 2019 Oct; 66(10):e27870. PubMed ID: 31222954
[TBL] [Abstract][Full Text] [Related]
31. Adult Donor Blood Products as Risk Factors for Central Venous Catheter-associated Thromboembolism in Neonates: A Retrospective Case-Control Study.
Badur CA; Bührer C; Dame C
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e255-e259. PubMed ID: 32459720
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation.
Lauw MN; Van der Holt B; Middeldorp S; Meijers JC; Cornelissen JJ; Biemond BJ
Thromb Haemost; 2013 Apr; 109(4):633-42. PubMed ID: 23364346
[TBL] [Abstract][Full Text] [Related]
33. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
Nowak-Göttl U; Kenet G; Mitchell LG
Best Pract Res Clin Haematol; 2009 Mar; 22(1):103-14. PubMed ID: 19285277
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients.
Schorling RM; Pfrepper C; Golombek T; Cella CA; Muñoz-Unceta N; Siegemund R; Engel C; Petros S; Lordick F; Knödler M
Oncol Res Treat; 2020; 43(9):414-427. PubMed ID: 32580190
[TBL] [Abstract][Full Text] [Related]
35. Identification of a "VTE-rich" population in pediatrics - Critically ill children with central venous catheters.
Tran M; Shein SL; Ji X; Ahuja SP
Thromb Res; 2018 Jan; 161():73-77. PubMed ID: 29207322
[TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
Hanson SJ; Punzalan RC; Greenup RA; Liu H; Sato TT; Havens PL
J Trauma; 2010 Jan; 68(1):52-6. PubMed ID: 20065757
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism in neonates and children.
Kenet G; Nowak-Göttl U
Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
[TBL] [Abstract][Full Text] [Related]
39. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
40. Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.
Koschade SE; Stratmann JA; Steffen B; Shaid S; Finkelmeier F; Serve H; Miesbach W; Brandts CH; Ballo O
Eur J Haematol; 2023 Apr; 110(4):426-434. PubMed ID: 36573351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
